These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 10074345)
1. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A. Li J; Byeon IJ; Ericson K; Poi MJ; O'Maille P; Selby T; Tsai MD Biochemistry; 1999 Mar; 38(10):2930-40. PubMed ID: 10074345 [TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor INK4: quantitative structure-function analyses of p18INK4C as an inhibitor of cyclin-dependent kinase 4. Li J; Poi MJ; Qin D; Selby TL; Byeon IJ; Tsai MD Biochemistry; 2000 Feb; 39(4):649-57. PubMed ID: 10651629 [TBL] [Abstract][Full Text] [Related]
3. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6. Noh SJ; Li Y; Xiong Y; Guan KL Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200 [TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C). Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039 [TBL] [Abstract][Full Text] [Related]
5. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a. Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052 [TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the CDK4/6 inhibitory protein p18INK4c provides insights into ankyrin-like repeat structure/function and tumor-derived p16INK4 mutations. Venkataramani R; Swaminathan K; Marmorstein R Nat Struct Biol; 1998 Jan; 5(1):74-81. PubMed ID: 9437433 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms. Suzuki T; Narita T; Uchida-Toita M; Yoshida M Virology; 1999 Jul; 259(2):384-91. PubMed ID: 10388662 [TBL] [Abstract][Full Text] [Related]
8. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Russo AA; Tong L; Lee JO; Jeffrey PD; Pavletich NP Nature; 1998 Sep; 395(6699):237-43. PubMed ID: 9751050 [TBL] [Abstract][Full Text] [Related]
9. Backbone dynamics of the CDK inhibitor p19(INK4d) studied by 15N NMR relaxation experiments at two field strengths. Renner C; Baumgartner R; Noegel AA; Holak TA J Mol Biol; 1998; 283(1):221-9. PubMed ID: 9761685 [TBL] [Abstract][Full Text] [Related]
10. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1. Phelps DE; Xiong Y Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177 [TBL] [Abstract][Full Text] [Related]
11. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines. Timmermann S; Hinds PW; Münger K Cell Growth Differ; 1997 Apr; 8(4):361-70. PubMed ID: 9101082 [TBL] [Abstract][Full Text] [Related]
12. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule. Fåhraeus R; Laín S; Ball KL; Lane DP Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Schreiber M; Muller WJ; Singh G; Graham FL Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428 [TBL] [Abstract][Full Text] [Related]
16. Structural characterization of the tumor suppressor p16, an ankyrin-like repeat protein. Boice JA; Fairman R Protein Sci; 1996 Sep; 5(9):1776-84. PubMed ID: 8880901 [TBL] [Abstract][Full Text] [Related]
17. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Jeffrey PD; Tong L; Pavletich NP Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804 [TBL] [Abstract][Full Text] [Related]
18. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Zindy F; Quelle DE; Roussel MF; Sherr CJ Oncogene; 1997 Jul; 15(2):203-11. PubMed ID: 9244355 [TBL] [Abstract][Full Text] [Related]
19. Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma. Morishita A; Masaki T; Yoshiji H; Nakai S; Ogi T; Miyauchi Y; Yoshida S; Funaki T; Uchida N; Kita Y; Funakoshi F; Usuki H; Okada S; Izuishi K; Watanabe S; Kurokohchi K; Kuriyama S Hepatology; 2004 Sep; 40(3):677-86. PubMed ID: 15349907 [TBL] [Abstract][Full Text] [Related]
20. The COOH terminus of p18INK4C distinguishes function from p16INK4A. Gump J; Turner S; Koh J Cancer Res; 2001 May; 61(10):3863-8. PubMed ID: 11358797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]